Human Neurotransmitter Laboratory, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia (M.D.E., M.P.S.).
Department of Surgery, Medical School, University of Minnesota, Minneapolis (J.W.O.).
Hypertension. 2024 Jun;81(6):1194-1205. doi: 10.1161/HYPERTENSIONAHA.123.21715. Epub 2024 Apr 1.
The importance of the sympathetic nervous system in essential hypertension has been recognized in 2 eras. The first was in early decades of the 20 century, through to the 1960s. Here, the sympathetic nervous system was identified as a target for the treatment of hypertension, and an extensive range of antiadrenergic therapies were developed. Then, after a period of lapsed interest, in a second era from 1985 on, the development of precise measures of human sympathetic nerve firing and transmitter release allowed demonstration of the importance of neural mechanisms in the initiation and maintenance of the arterial blood pressure elevation in hypertension. This led to the development of a device treatment of hypertension, catheter-based renal denervation, which we will discuss.
交感神经系统在原发性高血压中的重要性在 2 个时代得到了认可。第一个时代是 20 世纪早期,一直持续到 20 世纪 60 年代。在这个时代,交感神经系统被确定为治疗高血压的靶点,并且开发了广泛的抗肾上腺素能治疗方法。然后,在一段时间的兴趣减退之后,从 1985 年开始的第二个时代,精确测量人类交感神经放电和递质释放的方法的发展,使得神经机制在高血压患者动脉血压升高的起始和维持中的重要性得到了证明。这导致了一种高血压治疗装置——基于导管的肾脏去神经支配术的发展,我们将对此进行讨论。